ClinicalTrials.gg
Drug

Itraconazole clinical trials

Also written Sporanox, R 51,211 and PUR1900.

studies test it
129
open now
19
in phase 3
13
first study started
1991

How each study uses Itraconazole is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Itraconazole studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Approvals

The first approval found in each region, with its record

United States
11 Sept 1992 · SPORANOX · NDA 020083 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Itraconazole
90
Itraconazole 200 mg
7
Itraconazole (200 mg)
6
Lozanoc
6
Oriconazole
4

Brand

Sporanox
23
Sempera®
1

Development codes

R 51,211
4
PUR1900
2
JNJ-16269994
1

Studies by the year they started

118 studies that test it; most in 2024 (10)

Studies that test Itraconazole, by start year
YearStudies
19911
19981
20002
20031
20041
20062
20074
20084
20094
20102
20111
20134
20149
20155
20165
20174
20185
20196
20207
20219
20229
20238
202410
20256
20268

By phase

A phase 1/2 study counts in both.

Early Phase 1
6
Phase 1
61
Phase 2
30
Phase 3
13
Phase 4
13
No phase
17

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 62 · Other 67

Post Graduate Institute of Medical Education and Research, Chandigarh (7) · AstraZeneca (6) · National Institute of Allergy and Infectious Diseases (NIAID) (5) · Janssen, LP (5) · Combined Military Hospital Abbottabad (4) · Pfizer (3) · GRIN Therapeutics, Inc. (2) · Eli Lilly and Company (2)

Often tested with

Tested in the same studies.

Rifampin (15) · Fluconazole (8) · Terbinafine (5) · Rabeprazole (4) · Carbamazepine (2) · Isotretinoin (2) · Voriconazole (2) · Amphotericin B (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4

Studies that test Itraconazole.

Studies

Open first, then newest update. How each study uses Itraconazole is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 129

See all 129 studies that test Itraconazole →

Given beside what is tested · 244 — Itraconazole is usual care or a partner of the new treatment

Showing 20 of 244.

As the comparator · 17 — what is tested is compared with Itraconazole

What changed recently

From the registry's own updates since Oct 15, 2026.

Codes

What other systems call Itraconazole · ClinicalTrials.gg INT008621

  • MeSH (NLM) D017964ItraconazoleConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 304NUG5GF4ITRACONAZOLEConfirmed FDA, NLM, Wikidata
  • RxNorm 28031Confirmed FDA, Wikidata
  • Wikidata Q411229itraconazoleConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1138ItraconazoleOne source FDA
  • DrugBank DB01167One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.